Oramed Pharmaceuticals
ORMPOramed Pharmaceuticals, or Oramed (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem, Israel. Its shares are lis …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Oramed Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/4/2023 | Buy | Mayer, Arie | Director | $2.2 | $8,398 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)